Table 4

Association between clinical and laboratory variables with complications of type 2 diabetes in the study subjects

Variables†EstimateSEOR (95% CI)p
Complication versus no complication
 Waist circumference0.02770.01461.03 (1.00 to 1.06)0.058
 Cholesterol total−0.40240.17160.67 (0.48 to 0.94)0.019*
 eGFR−0.03540.01380.97 (0.94 to 0.99)0.010*
 Duration of type 2 diabetes0.50470.17071.66 (1.19 to 2.31)0.003*
Coronary artery disease (CAD) versus no CAD
 Creatinine−0.00470.00271.00 (0.99 to 1.00)0.085
 eGFR−0.02100.00810.98 (0.96 to 0.99)0.010*
 Smoking0.68390.27021.98 (1.17 to 3.38)0.011*
 Duration of type 2 diabetes0.22400.08551.25 (1.06 to 1.48)0.009*
Retinopathy versus no retinopathy
 Age−0.05860.01600.94 (0.91 to 0.97)0.00025*
 BMI0.06200.03091.06 (1.00 to 1.13)0.045
 Waist circumference−0.05740.01530.94 (0.91 to 0.97)0.00018*
 HbA1c−0.16690.08860.85 (0.71 to 1.00)0.0598
 Cholesterol-total1.25270.39733.50 (1.64 to 7.80)0.0016*
 Triglycerides−0.58210.21130.56 (0.37 to 0.84)0.0059*
 LDL-cholesterol−1.28450.43560.28 (0.12 to 0.64)0.0032*
 eGFR0.01440.00841.01 (1.00 to 1.03)0.085
Neuropathy versus no neuropathy
 Urea0.13350.05891.14 (1.02 to 1.29)0.023
  • †Only significant and suggestive associations are shown.

  • BMI, body mass index; eGFR, estimated glomerular filtration rate.